Kazunori Toyoda

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

P. Sandercock, J. Grotta, M. Kaste, 2014, The Lancet.

Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE)

L. McCullough, P. Sylaja, M. Azarpazhooh, 2020, Journal of Stroke and Cerebrovascular Diseases.

Thrombolysis for Wake-Up Stroke Versus Non–Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis

T. Kitazono, F. Boutitie, Mayumi Fukuda‐Doi, 2024, Stroke.

Presenting Symptoms and Diffusion-Weighted MRI Positivity by Time After Transient Neurologic Events

M. Koga, S. Coutts, K. Votova, 2023, Neurology.

Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial

H. Lutsep, S. Kasner, T. Tatlisumak, 2024, The Lancet Neurology.